Related Experiment Videos
Toward a dynamic real-time intraoperative permanent prostate brachytherapy methodology.
Louis Potters1, Emel Calguaru, Kenneth B Thornton
1Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center at Mercy Medical Center, Rockville Centre, NY, USA. PottersL@yahoo.com
Brachytherapy
|April 6, 2004
Summary
Real-time dynamic permanent prostate brachytherapy (PPB) with inverse planning shows promising dosimetry results. Intraoperative assessments closely correlate with post-implant CT dosimetry, suggesting potential to streamline treatment evaluation.
Area of Science:
- Medical Physics
- Oncology
- Radiotherapy
Background:
- Permanent Prostate Brachytherapy (PPB) is a common treatment for localized prostate cancer.
- Accurate dosimetry is crucial for effective treatment and minimizing side effects.
- Traditional dosimetry relies on post-operative imaging, delaying assessment.
Purpose of the Study:
- To evaluate dosimetry and source location accuracy in real-time dynamic PPB using inverse treatment planning.
- To compare intraoperative dosimetry with post-operative CT-based dosimetry.
Main Methods:
- Developed a dynamic PPB algorithm with inverse planning and real-time transrectal ultrasound guidance.
- Monitored dosimetry during seed placement with real-time assessments and adjustments.
- Performed intraoperative dosimetry (OR-D) and compared it with post-operative CT dosimetry (CT-D) at 3 weeks.
- Developed a matrix algorithm to match seed locations between ultrasound and CT data.
Main Results:
- Twenty-six patients underwent dynamic PPB.
- Mean D90 values were similar between OR-D (109%) and CT-D (105%), with no statistically significant difference (p=0.894).
- V100 and V150 analyses also showed insignificant differences between OR-D and CT-D.
- Mean root-mean-square error for seed location matching was 4.6 mm.
Conclusions:
- Real-time dynamic PPB with inverse planning demonstrates good correlation between intraoperative and post-operative dosimetry.
- The developed algorithm shows potential for improving implant dosimetry and documenting dose accurately intraoperatively.
- Further studies are needed to confirm the benefits and potential to eliminate the need for post-implant dosimetry.